本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kazia Therapeutics Limited

7.80
-0.1100-1.39%
成交量:2.09萬
成交額:16.33萬
市值:8,912.98萬
市盈率:-0.63
高:8.01
開:7.81
低:7.65
收:7.91
52周最高:17.40
52周最低:2.86
股本:1,142.69萬
流通股本:1,058.34萬
量比:0.39
換手率:0.20%
股息:- -
股息率:- -
每股收益(TTM):-12.3849
每股收益(LYR):-12.3849
淨資產收益率:-3891.64%
總資產收益率:-64.28%
市淨率:-15.26
市盈率(LYR):-0.63

資料載入中...

2025/12/19

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/12/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/11/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/09/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/02/03

SEC問詢函

Form CORRESP - Correspondence
2025/01/30

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/11/15

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/11

SEC問詢函

Form CORRESP - Correspondence
2024/08/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/03

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

SEC問詢函

Form CORRESP - Correspondence
2024/06/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/06/01

SEC問詢函

Form CORRESP - Correspondence
2024/05/29

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/03

SEC問詢函

Form CORRESP - Correspondence
2024/01/31

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/10/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]